Engineering Natural Product Nanomedicines to Modulate Tumor Immunometabolism for Enhanced Cancer Immunotherapy
Molecules · 03.11.2026 · 31 (21) · 3965
DOI: 10.3390/molecules31213965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 03.11.2026. Verfasst von Yang Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: Immunotherapy, Nanomedicine, Biological Products, Neoplasms. Die Arbeit nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, the Key Scientific Research Project of the Education Department of Hunan Province.
Abstract (Originalsprache)
Tumor metabolic reprogramming contributes to an immunosuppressive microenvironment and limits the efficacy of cancer immunotherapy. Natural products can regulate multiple metabolic pathways, but their therapeutic application is often restricted by poor bioavailability and insufficient tumor exposure. Nanomedicine offers a means to overcome these limitations while enabling more selective metabolic intervention. This review examines how natural product nanomedicines remodel tumor immunometabolism and influence antitumor immunity. Current evidence shows that these nanomedicines can regulate glucose and lactate metabolism, lipid and amino acid-associated metabolism, and mitochondrial/redox homeostasis. Such metabolic remodeling has been associated with improved CD8+ T-cell activity, altered immunosuppressive immune populations, induction of immunogenic cell death, and improved responses to immune checkpoint blockade in selected studies. However, causal links between metabolic regulation and immune remodeling remain insufficiently defined, and metabolic interventions may exert distinct effects across tumor and immune cell populations. Future studies should emphasize cell-specific targeting, direct assessment of metabolic target engagement, and pharmacokinetic-pharmacodynamic relationships. Natural product nanomedicines therefore represent a promising platform for integrating metabolic intervention with cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Southern California, Los Angeles, CA 90033, USA.
- No. 923 Hospital of Joint Logistic Support Force of PLA, Nanning 530022, China.
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
ORCID-Profile: Linghui Zou
Förderung
- Natural Science Foundation of Hunan Province
- the Key Scientific Research Project of the Education Department of Hunan Province
Zitieren
APA
Xiao, Y., Lan, S., Dai, Y., Liu, X., Huang, C., Yang, C., Wang, Z., & Zou, L. (2026). Engineering Natural Product Nanomedicines to Modulate Tumor Immunometabolism for Enhanced Cancer Immunotherapy. Molecules, 31(21), 3965. https://doi.org/10.3390/molecules31213965
Vancouver
Xiao Y, Lan S, Dai Y, Liu X, Huang C, Yang C, et al. Engineering Natural Product Nanomedicines to Modulate Tumor Immunometabolism for Enhanced Cancer Immunotherapy. Molecules. 2026;31(21):3965. doi:10.3390/molecules31213965
BibTeX
@article{Xiao2026,
author = {Xiao, Yang and Lan, Shaowen and Dai, Yuping and Liu, Xuenan and Huang, Chaowen and Yang, Changming and Wang, Zhiqi and Zou, Linghui},
title = {Engineering Natural Product Nanomedicines to Modulate Tumor Immunometabolism for Enhanced Cancer Immunotherapy},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3965},
doi = {10.3390/molecules31213965}
}
EUVIMED